Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
401 participants
OBSERVATIONAL
2015-12-11
2017-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Moreover health care resource consumption will be observed during the observation period.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating a Mobile Self-management Application for Patients With COPD Chronic Obstructive Pulmonary Disease
NCT04540562
Air as a Placebo: Increasing the Respiratory Performance of People With COPD Through Simple Expectations of Improvement
NCT05218564
Comprehensive Disease Management Program in Chronic Obstructive Pulmonary Disease (COPD) Patients in the Community
NCT00982384
Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD
NCT05718102
Self-management Behaviors and Resilience Among Chronic Obstructive Pulmonary Disease Patients
NCT05459740
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients must have a documented diagnosis of chronic obstructive pulmonary disease (COPD)
3. Patients with no exacerbations in the last 3 months
4. Patients requiring regular treatment according to GOLD guidelines, i.e.: undergoing stable pharmacological treatment for COPD since at least 3 months
5. Written informed consent to both participation in the study and privacy form
6. Patients capable of discernment and able to read or write in Italian language.
Exclusion Criteria
2. Patients naïve to pharmacological treatment for COPD
3. Diagnosis of Asthma COPD Overlap Syndrome (ACOS)
40 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boehringer Ingelheim
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Boehringer Ingelheim
Role: STUDY_CHAIR
Boehringer Ingelheim
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo
Alessandria, , Italy
I.N.R.C.A. - I.R.C.C.S Ospedale Geriatrico Ugo Sestili
Ancona, , Italy
Ospedale Reg Umberto Parini
Aosta, , Italy
A. O. Giuseppe Moscati
Avellino, , Italy
Ospedale Civile di Battipaglia
Battipaglia Salerno, , Italy
IRCCS - Istituto Scientifico di Cassano delle Murge
Cassano Murge Bari, , Italy
Azienda Ospedaliera Universitaria Arcispedale Sant'Anna
CONA (FE), , Italy
Policlinico San Martino
Genova, , Italy
Az. Unità Loc. Socio-Sanitaria 21 -
Legnago, , Italy
Spedali Riuniti di Livorno
Livorno, , Italy
Fondazione Salvatore Maugeri
Milan, , Italy
Asst Santi Paolo E Carlo
Milan, , Italy
Osp. dei Colli Monaldi-Cotugno
Napoli, , Italy
Azienda Sanitaria Ospedale S. Luigi Gonzaga
Orbassano, , Italy
Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello
Palermo, , Italy
Fondazione IRCCS Policlinico S. Matteo
Pavia, , Italy
Azienda Unità Sanitaria Locale di Reggio Emilia
Reggio Emilia, , Italy
Pol. Universitario Tor Vergata
Roma, , Italy
Ospedale Civile Mazzini
Teramo, , Italy
ASL 4 di Terni
Terni, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Contoli M, Rogliani P, Di Marco F, Braido F, Corsico AG, Amici CA, Piro R, Sarzani R, Lessi P, Scognamillo C, Scichilone N, Santus P; SAT Study Group. Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study. Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619888128. doi: 10.1177/1753466619888128.
Corsico AG, Braido F, Contoli M, Di Marco F, Rogliani P, Scognamillo C, Olivi I, Santus P, Scichilone N, Lazzaro C. Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up. Respir Med. 2019 Jul;153:68-75. doi: 10.1016/j.rmed.2019.05.017. Epub 2019 May 29.
Baiardini I, Rogliani P, Santus P, Corsico AG, Contoli M, Scichilone N, Di Marco F, Lessi P, Scognamillo C, Molinengo G, Ferri F, Patella V, Fiorentino G, Carone M, Braido F. Disease awareness in patients with COPD: measurement and extent. Int J Chron Obstruct Pulmon Dis. 2018 Dec 17;14:1-11. doi: 10.2147/COPD.S179784. eCollection 2019.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1237.51
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.